EP4716539A1 - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
EP4716539A1
EP4716539A1 EP24809860.0A EP24809860A EP4716539A1 EP 4716539 A1 EP4716539 A1 EP 4716539A1 EP 24809860 A EP24809860 A EP 24809860A EP 4716539 A1 EP4716539 A1 EP 4716539A1
Authority
EP
European Patent Office
Prior art keywords
composition
pharmaceutical composition
infection
disease
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24809860.0A
Other languages
German (de)
English (en)
Inventor
Roger Phillip Gordon Leach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aerotech Australia Pty Ltd
Original Assignee
Aerotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2023901609A external-priority patent/AU2023901609A0/en
Application filed by Aerotech Australia Pty Ltd filed Critical Aerotech Australia Pty Ltd
Publication of EP4716539A1 publication Critical patent/EP4716539A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition pharmaceutique d'un sel de magnésium avec de l'acide alpha-lipoïque et/ou du méthylsulfonylméthane (MSM), utile pour le traitement, la prévention ou la réduction de la gravité d'infections virales et/ou d'affections cutanées. L'invention concerne également des procédés de préparation de la composition pharmaceutique, et des procédés d'utilisation de la composition pharmaceutique en thérapie.
EP24809860.0A 2023-05-23 2024-05-22 Composition pharmaceutique Pending EP4716539A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2023901609A AU2023901609A0 (en) 2023-05-23 Pharmaceutical composition
PCT/AU2024/050528 WO2024239066A1 (fr) 2023-05-23 2024-05-22 Composition pharmaceutique

Publications (1)

Publication Number Publication Date
EP4716539A1 true EP4716539A1 (fr) 2026-04-01

Family

ID=93588618

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24809860.0A Pending EP4716539A1 (fr) 2023-05-23 2024-05-22 Composition pharmaceutique

Country Status (4)

Country Link
EP (1) EP4716539A1 (fr)
CN (1) CN121152629A (fr)
AU (1) AU2024276277A1 (fr)
WO (1) WO2024239066A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025151037A1 (fr) * 2024-01-11 2025-07-17 Stir Pharma Limited Méthodes thérapeutiques et compositions associées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080038219A1 (en) * 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
KR20220113567A (ko) * 2021-02-05 2022-08-16 이광미 염증 질환의 개선용 조성물

Also Published As

Publication number Publication date
WO2024239066A1 (fr) 2024-11-28
CN121152629A (zh) 2025-12-16
AU2024276277A1 (en) 2025-11-13

Similar Documents

Publication Publication Date Title
AU778524B2 (en) Anhydrous topical skin preparations
US8735393B2 (en) Anhydrous topical skin preparations
WO2001005400A1 (fr) Preparations de nitroimidazole a usage externe pour traiter la dermatose
CN102159198A (zh) 皮肤感染的局部治疗
AU2008203101A1 (en) Topical compositions comprising telmesteine for treating dermatological disorders
KR101894521B1 (ko) 흉터치료를 위한 국소용 약학적 조성물
WO2024239066A1 (fr) Composition pharmaceutique
JP3187806B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
EP4382104A1 (fr) Dyclonine pour le traitement topique du syndrome main-pied
JP2001270826A (ja) 皮膚疾患治療・予防用外用剤
JP2001163783A (ja) 皮膚疾患治療用外用剤
EP1159956B1 (fr) Préparations anhydres topiques pour la peau
JP3568881B2 (ja) 皮膚疾患治療用外用剤
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
EP1700597B1 (fr) Composition pharmaceutique comprenant en association ubidecarenone, dexpanthenol et chlorhexidine ou un de ses sels pharmaceutiquement acceptables pour application cutanée
KR20020035131A (ko) 덱스라족산의 건선 치료 용도
JP2001288082A (ja) 乾癬治療・予防用外用剤
JP2025534394A (ja) 疼痛及び他の医学的状態の治療のための硫酸化グリコサミノグリカン及びそれに由来する断片の保存安定性製剤
WO2016133471A1 (fr) Composition topique contenant de la mupirocine et du dexpanthénol
HK1031342B (en) Anhydrous topical skin preparation comprising ketoconazole
MXPA00007720A (en) Anhydrous topical skin preparations

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251023

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR